ENTRY       D12634                      Drug
NAME        Donislecel (USAN);
            Lantidra (TN)
PRODUCT     LANTIDRA (CellTrans)
REMARK      Product: D12634<US>
EFFICACY    Antidiabetic
  DISEASE   Type 1 diabetes [DS:H00408]
  TYPE      Cellular therapy product
COMMENT     Therapy for allogeneic pancreatic islet cell
BRITE       New drug approvals in the USA [br08319.html]
             Cellular and gene therapy products
              D12634
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12634
///
